Covidien (COV) Patent Enforced Against China-Based Companies
11/22/2011 8:40:59 AM
NEW HAVEN, Conn.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products, today announced that German customs authorities, in cooperation with Covidien, have seized quantities of imported surgical stapling products that copy Covidien’s designs and infringe one of its patents. The government seizures collected infringing surgical stapling products that had been imported into the German market from two China-based companies.
comments powered by